The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

A recent study published in the Journal of Clinical Endocrinology & Metabolism found that testosterone treatments had no effect on men suffering from ejaculatory dysfunction (EjD), contradicting earlier studies that had theorized that low testosterone levels might contribute to EjD.

The study examined 66 men with low testosterone levels and symptoms of EjD, and found no different in ejaculate volume, orgasmic function, sexual activity log score, or both/satisfaction score between the test group and a placebo group.

Testosterone therapy is an approved treatment for a condition present when the pituitary glands or testicles do not produce enough hormones. The medications come in various forms, including:

  • Gels
  • Injections
  • Patches
  • Capsules
  • Boosters

Despite no proven benefits, men frequently also use Low T medications to enhance physical performance, improve sex drive, treat erectile dysfunction, and lessen the symptoms of aging.

The U.S. Food and Drug Administration (FDA) has only approved testosterone products for use when low testosterone levels are associated with a specific medical condition. The agency recently ordered drug manufacturers to add warnings to testosterone therapy labels about heart attack and stroke risks and cautioned doctors against over-prescribing these medications to men who have low testosterone levels solely due to the aging process.

Risks of Testosterone Treatment

There are many risks, and there is now more evidence of fewer benefits, associated with Low T treatments. Thousands of testosterone treatment lawsuits are anticipated against testosterone drug manufacturers such as Abbott, AbbVie, Auxillium Pharmaceuticals, Pfizer, and many others.

Comments for this article are closed.